SAN DIEGO, CA / ACCESSWIRE / February 12, 2018 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain purchasers of NASDAQ: VIVO shares against Meridian Bioscience, Inc. over alleged violations of Securities Laws.
Investors, who purchased shares of Meridian Bioscience, Inc. (NASDAQ: VIVO) in early 2016 or earlier and continue to hold any of those NASDAQ: VIVO shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On November 15, 2017, a lawsuit was filed against Meridian Bioscience, Inc. over alleged securities laws violations. The plaintiff alleged that the defendants issued materially false and/or misleading statements and/or failed to disclose that Defendant's lead tests provide inaccurate results and that as a result of the foregoing, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased Meridian Bioscience, Inc. (NASDAQ: VIVO) shares should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
SOURCE: Shareholders Foundation, Inc.
